OPHTHALMOLOGY

Gender Differences in Patient-Physician Communication in Ophthalmic Practice, Pre- and Post-COVID-19 Period

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Gender Differences in Patient-Physician Communication in Ophthalmic Practice, Pre- and Post-COVID-19 Period

Highlights • Gender differences exist in ophthalmologist communication patterns. • Female ophthalmologists seem to use a more patient-centered communication style. • The COVID-19 pandemic impacted ophthalmologist communication patterns. • Burnout…

read more

Neurofibromatosis Type 1 (NF1)–Related Ocular Signs: New Insights on Their Prevalence, Incidence, and Genotype-Phenotype Correlation in NF1 Children

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Neurofibromatosis Type 1 (NF1)–Related Ocular Signs: New Insights on Their Prevalence, Incidence, and Genotype-Phenotype Correlation in NF1 Children

PURPOSE To assess, in a large pediatric population affected by neurofibromatosis type 1 (NF1), the prevalence, incidence, age of onset, and genotype correlation of the main NF1-related ocular signs, including…

read more

Evaluating the Global Consensus on Keratoconus and Ectatic Diseases Agreements Reached on Subclinical Keratoconus

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Evaluating the Global Consensus on Keratoconus and Ectatic Diseases Agreements Reached on Subclinical Keratoconus

Purpose To evaluate the consensus agreements reached in the Global Consensus on Keratoconus and Ectatic Diseases project for subclinical keratoconus, specifically that posterior corneal elevation abnormalities must be present to…

read more

Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration

PURPOSE To investigate the safety, tolerability, and efficacy of intravitreal injection of galegenimab, an anti-HtrA1 FAb, in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD). DESIGN Phase…

read more

Epidemiologic Study of Pediatric Uveitis and its Ophthalmic Complications Using the Korean National Health Insurance Claim Database

Jul 26, 2025 by in OPHTHALMOLOGY Comments Off on Epidemiologic Study of Pediatric Uveitis and its Ophthalmic Complications Using the Korean National Health Insurance Claim Database

PURPOSE To investigate the incidence and ophthalmic complications of pediatric uveitis using the Korean National Health Insurance (NHI) Service database. DESIGN Nationwide population-based longitudinal cohort study. METHODS This study used…

read more

Recurrent polypoidal lesions after achieving inactive polypoidal choroidal vasculopathy following 1-year fixed-dosing aflibercept treatments

Apr 20, 2025 by in OPHTHALMOLOGY Comments Off on Recurrent polypoidal lesions after achieving inactive polypoidal choroidal vasculopathy following 1-year fixed-dosing aflibercept treatments

Abstract Purpose Polypoidal choroidal vasculopathy (PCV) may have frequent recurrences after fluid resolution, but time to recurrence is unclear. This study explored time to first polypoidal recurrence after 1-year fixed-dosing…

read more

Psychometric evaluation and computerized adaptive testing simulations of age-related macular degeneration quality of life item banks

Apr 20, 2025 by in OPHTHALMOLOGY Comments Off on Psychometric evaluation and computerized adaptive testing simulations of age-related macular degeneration quality of life item banks

Abstract Purpose To optimize the psychometric properties of age-related macular degeneration (AMD) quality of life (QoL) item banks (IBs), and evaluate their performance using computerized adaptive testing (CAT) simulations. Design…

read more
Get Clinical Tree app for offline access